glp-1 therapy meal timing weight loss studies Dietary intake by patients taking and dual GIP/GLP-1 receptor agonists: A narrative review and discussion of research needs Weight loss maintenance after discontinuing

The more options people have, the better, says Avlin Imaeda, MD, PhD, a Yale Medicine gastroenterologist who is board-certified in obesity medicine

Semaglutide 2.4 mg (Wegovy) has demonstrated cardiovascular benefits in the SELECT trial, though this benefit should not be assumed for all medications in this class

These efforts underscore the potential of GLP-1RAs to offer novel treatment options and improve patient outcomes across a range of inflammatory diseases.

Alcohol: Not strictly contraindicated, but can worsen nausea and increase low blood sugar risk in people with diabetes or on certain medications

The Subscription Trend: Telehealth GLP-1, Lemme GLP-1 and Other Services Some companies now market subscription-based GLP-1 programs directly to consumers

Mounjaro is approved to help manage type 2 diabetes while Zepbound is approved for weight loss in those with obesity or with overweight and at least one weight-related condition like high cholesterol